1|Page
NAMS MENOPAUSE CERTIFICATION EXAM NEWEST 2025/2026
ACTUAL EXAM WITH COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS (100% VERIFIED ANSWERS) |ALREADY
GRADED A+| ||PROFESSOR VERIFIED||
Weight loss with Naltrexone SR/Bupropion SR (Contrave) -
ANSWER-~5-6.4%
Dopamine and norepinephrine reuptake inhibitor and u-opioid
receptor antagonist
C/I: htn, seizures, eating disorder, opioid use,
SE: nausea, headache
Weight loss with liraglutide - ANSWER-GLP-1 receptor agonist
Dose up to 3mg daily in .6mg steps
Weight loss ~7-10%
C/I: pancreatitis, fam hx of medullary thyroid, multiple endocrine
neoplasia
S/E: nausea, diarrhea, vomiting constipation
Weight loss with semaglutide - ANSWER-~14-16%
GLP-1 receptor agonist
,2|Page
Dose up yo 2.4mg daily in slow weekly dose titration
C/I: pancreatitis, fam hx of medullary thyroid, multiple endocrine
neoplasia
S/E: nausea, diarrhea, vomiting constipation
Climacteric phase - ANSWER-The period of endrocrinologic,
somatic, and transitory psychologic changes that occur around
the time of menopause.
Early menopause - ANSWER-LMP before age 45
Late menopause - ANSWER-LMP after age 54
Primary ovarian insufficiency - ANSWER-Menopause that occurs
before age 40
Early menopause transition (stage -2) - ANSWER-Persistent
difference of 7 days or more in the length of consecutive cycles.
Late menopause transition (stage -1) - ANSWER-60 or more
consecutive days of amenorrhea
,3|Page
Luteal out of phase event (LOOP) - ANSWER-Explains why some
perimenopausal women have elevated estrogen level
sometimes...In the early menopause transition, elevated FSH
levels are adequate to recruit a second follicle which results in a
follicular phase-like rise in estradiol secretion superimposed on
the mid-to-late luteal phase of the ongoing ovulatory cycle.
Obese women and estradiol levels during menopause -
ANSWER-Obese women are more likely to have anovulatory
cycles with high estradiol levels. They are also more likely to have
lower premenopause yet higher postmenopause estradiol levels
compared with women of normal weight. (why they are at higher
risk of endometrial cancer)
Chinese and Japanese women - ANSWER-These ethnic groups
have lower estradiol levels then white, black and hispanic women.
Stage +2 - ANSWER-late menopause stage: 5-8 years after FMP.
Somatic aging predominates. Increased genitourinary symptoms.
, 4|Page
Stages +1a, +1b, +1c - ANSWER-early post menopause: 2 years
after FMP. FSH rises, estradiol decreases. VMS predominate.
Elevated FSH, LH - ANSWER-Endocrine labs after menopause
AMH, inhibin B - ANSWER-These hormones work during
reproductive years to not deplete follicle pool too quickly.
Phases during menopause transition and PMS symptoms -
ANSWER-Menstrual cycle variable, persistent >7 day difference
between difference in length of consecutive cycles.
How to respond if a patient requests FSH lab? - ANSWER-many
pitfalls, variable depending on the day of the cycle you draw the
lab, normal or low FSH is not helpful.
The potentially superior marker of menopause, a lab. - ANSWER-
AMH
NAMS MENOPAUSE CERTIFICATION EXAM NEWEST 2025/2026
ACTUAL EXAM WITH COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS (100% VERIFIED ANSWERS) |ALREADY
GRADED A+| ||PROFESSOR VERIFIED||
Weight loss with Naltrexone SR/Bupropion SR (Contrave) -
ANSWER-~5-6.4%
Dopamine and norepinephrine reuptake inhibitor and u-opioid
receptor antagonist
C/I: htn, seizures, eating disorder, opioid use,
SE: nausea, headache
Weight loss with liraglutide - ANSWER-GLP-1 receptor agonist
Dose up to 3mg daily in .6mg steps
Weight loss ~7-10%
C/I: pancreatitis, fam hx of medullary thyroid, multiple endocrine
neoplasia
S/E: nausea, diarrhea, vomiting constipation
Weight loss with semaglutide - ANSWER-~14-16%
GLP-1 receptor agonist
,2|Page
Dose up yo 2.4mg daily in slow weekly dose titration
C/I: pancreatitis, fam hx of medullary thyroid, multiple endocrine
neoplasia
S/E: nausea, diarrhea, vomiting constipation
Climacteric phase - ANSWER-The period of endrocrinologic,
somatic, and transitory psychologic changes that occur around
the time of menopause.
Early menopause - ANSWER-LMP before age 45
Late menopause - ANSWER-LMP after age 54
Primary ovarian insufficiency - ANSWER-Menopause that occurs
before age 40
Early menopause transition (stage -2) - ANSWER-Persistent
difference of 7 days or more in the length of consecutive cycles.
Late menopause transition (stage -1) - ANSWER-60 or more
consecutive days of amenorrhea
,3|Page
Luteal out of phase event (LOOP) - ANSWER-Explains why some
perimenopausal women have elevated estrogen level
sometimes...In the early menopause transition, elevated FSH
levels are adequate to recruit a second follicle which results in a
follicular phase-like rise in estradiol secretion superimposed on
the mid-to-late luteal phase of the ongoing ovulatory cycle.
Obese women and estradiol levels during menopause -
ANSWER-Obese women are more likely to have anovulatory
cycles with high estradiol levels. They are also more likely to have
lower premenopause yet higher postmenopause estradiol levels
compared with women of normal weight. (why they are at higher
risk of endometrial cancer)
Chinese and Japanese women - ANSWER-These ethnic groups
have lower estradiol levels then white, black and hispanic women.
Stage +2 - ANSWER-late menopause stage: 5-8 years after FMP.
Somatic aging predominates. Increased genitourinary symptoms.
, 4|Page
Stages +1a, +1b, +1c - ANSWER-early post menopause: 2 years
after FMP. FSH rises, estradiol decreases. VMS predominate.
Elevated FSH, LH - ANSWER-Endocrine labs after menopause
AMH, inhibin B - ANSWER-These hormones work during
reproductive years to not deplete follicle pool too quickly.
Phases during menopause transition and PMS symptoms -
ANSWER-Menstrual cycle variable, persistent >7 day difference
between difference in length of consecutive cycles.
How to respond if a patient requests FSH lab? - ANSWER-many
pitfalls, variable depending on the day of the cycle you draw the
lab, normal or low FSH is not helpful.
The potentially superior marker of menopause, a lab. - ANSWER-
AMH
